This report contains market size and forecasts of Hepatitis B Therapeutics in Global, including the following market information:
Global Hepatitis B Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Hepatitis B Therapeutics market was valued at 2563.9 million in 2020 and is projected to reach US$ 2871.2 million by 2027, at a CAGR of 2.9% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis B Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Hepatitis B Therapeutics Market Segment Percentages, By Type, 2020 (%)
Hepatitis B Vaccine
Anti-viral Drugs
China Hepatitis B Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Hepatitis B Therapeutics Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Hepatitis B Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Hepatitis B Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Hepatitis B Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Hepatitis B Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
GlaxoSmithKline
Bristol-Myers Squibb
Novira Therapeutics
Johnson & Johnson
Abivax
F. Hoffmann- La Roche
Novartis
Merck
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Hepatitis B Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis B Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis B Therapeutics Overall Market Size
2.1 Global Hepatitis B Therapeutics Market Size: 2021 VS 2027
2.2 Global Hepatitis B Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hepatitis B Therapeutics Players in Global Market
3.2 Top Global Hepatitis B Therapeutics Companies Ranked by Revenue
3.3 Global Hepatitis B Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis B Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Hepatitis B Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis B Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Hepatitis B Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Hepatitis B Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis B Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Hepatitis B Vaccine
4.1.3 Anti-viral Drugs
4.2 By Type - Global Hepatitis B Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Hepatitis B Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Hepatitis B Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Hepatitis B Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis B Therapeutics Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Hepatitis B Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Hepatitis B Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Hepatitis B Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Hepatitis B Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Hepatitis B Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Hepatitis B Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Hepatitis B Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Hepatitis B Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Hepatitis B Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Hepatitis B Therapeutics Revenue, 2016-2027
6.3.2 US Hepatitis B Therapeutics Market Size, 2016-2027
6.3.3 Canada Hepatitis B Therapeutics Market Size, 2016-2027
6.3.4 Mexico Hepatitis B Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Hepatitis B Therapeutics Revenue, 2016-2027
6.4.2 Germany Hepatitis B Therapeutics Market Size, 2016-2027
6.4.3 France Hepatitis B Therapeutics Market Size, 2016-2027
6.4.4 U.K. Hepatitis B Therapeutics Market Size, 2016-2027
6.4.5 Italy Hepatitis B Therapeutics Market Size, 2016-2027
6.4.6 Russia Hepatitis B Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Hepatitis B Therapeutics Market Size, 2016-2027
6.4.8 Benelux Hepatitis B Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Hepatitis B Therapeutics Revenue, 2016-2027
6.5.2 China Hepatitis B Therapeutics Market Size, 2016-2027
6.5.3 Japan Hepatitis B Therapeutics Market Size, 2016-2027
6.5.4 South Korea Hepatitis B Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Hepatitis B Therapeutics Market Size, 2016-2027
6.5.6 India Hepatitis B Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Hepatitis B Therapeutics Revenue, 2016-2027
6.6.2 Brazil Hepatitis B Therapeutics Market Size, 2016-2027
6.6.3 Argentina Hepatitis B Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hepatitis B Therapeutics Revenue, 2016-2027
6.7.2 Turkey Hepatitis B Therapeutics Market Size, 2016-2027
6.7.3 Israel Hepatitis B Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Hepatitis B Therapeutics Market Size, 2016-2027
6.7.5 UAE Hepatitis B Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Hepatitis B Therapeutics Major Product Offerings
7.1.4 GlaxoSmithKline Hepatitis B Therapeutics Revenue in Global (2016-2021)
7.1.5 GlaxoSmithKline Key News
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporate Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Hepatitis B Therapeutics Major Product Offerings
7.2.4 Bristol-Myers Squibb Hepatitis B Therapeutics Revenue in Global (2016-2021)
7.2.5 Bristol-Myers Squibb Key News
7.3 Novira Therapeutics
7.3.1 Novira Therapeutics Corporate Summary
7.3.2 Novira Therapeutics Business Overview
7.3.3 Novira Therapeutics Hepatitis B Therapeutics Major Product Offerings
7.3.4 Novira Therapeutics Hepatitis B Therapeutics Revenue in Global (2016-2021)
7.3.5 Novira Therapeutics Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Hepatitis B Therapeutics Major Product Offerings
7.4.4 Johnson & Johnson Hepatitis B Therapeutics Revenue in Global (2016-2021)
7.4.5 Johnson & Johnson Key News
7.5 Abivax
7.5.1 Abivax Corporate Summary
7.5.2 Abivax Business Overview
7.5.3 Abivax Hepatitis B Therapeutics Major Product Offerings
7.5.4 Abivax Hepatitis B Therapeutics Revenue in Global (2016-2021)
7.5.5 Abivax Key News
7.6 F. Hoffmann- La Roche
7.6.1 F. Hoffmann- La Roche Corporate Summary
7.6.2 F. Hoffmann- La Roche Business Overview
7.6.3 F. Hoffmann- La Roche Hepatitis B Therapeutics Major Product Offerings
7.6.4 F. Hoffmann- La Roche Hepatitis B Therapeutics Revenue in Global (2016-2021)
7.6.5 F. Hoffmann- La Roche Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Hepatitis B Therapeutics Major Product Offerings
7.4.4 Novartis Hepatitis B Therapeutics Revenue in Global (2016-2021)
7.7.5 Novartis Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Hepatitis B Therapeutics Major Product Offerings
7.8.4 Merck Hepatitis B Therapeutics Revenue in Global (2016-2021)
7.8.5 Merck Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Hepatitis B Therapeutics Market Opportunities & Trends in Global Market
Table 2. Hepatitis B Therapeutics Market Drivers in Global Market
Table 3. Hepatitis B Therapeutics Market Restraints in Global Market
Table 4. Key Players of Hepatitis B Therapeutics in Global Market
Table 5. Top Hepatitis B Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Hepatitis B Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Hepatitis B Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Hepatitis B Therapeutics Product Type
Table 9. List of Global Tier 1 Hepatitis B Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type